Singhal et al. demonstrated that normobaric hyperoxia treatment during focal cerebral ischemia–reperfusion does not increase oxidative stress, as measured by heme oxygenase-1 induction and protein carbonyl formation in the samples of whole hemisphere[11]. The gene discussed is HMOX1; the disease is brain ischemia.